ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $85 | -26.7% | 36,923 | -3.2% | 0.01% | -27.3% |
| Q1 2023 | $116 | -57.5% | 38,160 | -67.4% | 0.01% | -67.6% |
| Q4 2022 | $273 | -99.8% | 117,191 | +23.6% | 0.03% | +41.7% |
| Q3 2022 | $181,000 | +311.4% | 94,800 | +487.5% | 0.02% | +242.9% |
| Q2 2022 | $44,000 | -54.6% | 16,136 | -50.3% | 0.01% | -46.2% |
| Q1 2022 | $97,000 | -90.6% | 32,453 | -89.5% | 0.01% | -92.4% |
| Q1 2021 | $1,032,000 | +1009.7% | 309,839 | +1081.6% | 0.17% | +1040.0% |
| Q4 2020 | $93,000 | – | 26,221 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |